Med Vet Entomol 1996,10(3):241–246.Selleckchem LY2109761 PubMedCrossRef 11. Emmons RW, Ruskin J, Bissett ML, Uyeda DA, Wood RM, Lear CL: Tularemia in a mule deer. J Wildl Dis 1976,12(3):459–463.PubMed 12. Greco D, Ninu

E: A family outbreak of tularemia. Eur J Epidemiol 1985,1(3):232–233.PubMedCrossRef 13. Selleckchem LY3023414 Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjostedt A: An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun 2003,71(10):5940–5950.PubMedCrossRef 14. Clemens DL, Lee BY, Horwitz MA: Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 2005,73(9):5892–5902.PubMedCrossRef 15. Forestal CA, Malik M, Catlett SV, Savitt AG, Benach JL, Sellati TJ, Furie MB: Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis 2007,196(1):134–137.PubMedCrossRef 16. Yu JJ, Raulie EK, Murthy AK, Guentzel MN, Klose KE, Arulanandam BP: The presence of infectious extracellular Francisella

tularensis subsp. novicida in murine plasma after pulmonary challenge. Eur J Clin Microbiol Infect Dis 2008,27(4):323–325.PubMedCrossRef 17. Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR: Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol 2006,80(4):774–786.PubMedCrossRef 18. Barker JH, McCaffrey

RL, Baman NK, Allen LA, selleck inhibitor Weiss JP, Nauseef WM: The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils. Microbes Infect 2009,11(8–9):762–9.PubMedCrossRef 19. Sandstrom G, Lofgren S, Tarnvik A: A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun 1988,56(5):1194–1202.PubMed 20. Ben Nasr A, Klimpel GR: Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J Leukoc Biol MYO10 2008,84(1):77–85.PubMedCrossRef 21. Lahteenmaki K, Kuusela P, Korhonen TK: Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 2001,25(5):531–552.PubMedCrossRef 22. Sun H: The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 2006, 21:281–288. 23. Lahteenmaki K, Edelman S, Korhonen TK: Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 2005,13(2):79–85.PubMedCrossRef 24. Degen JL, Bugge TH, Goguen JD: Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007,5(Suppl 1):24–31.PubMedCrossRef 25.